MISTIE-III Mobile at App Store analyse

App power index: 100 (based on ranks around App Stores today)
Health & Fitness
Developer: Johns Hopkins University School of Medicine
Price: 0 free
Current version: 1.0, last update: 7 years ago
First release : 17 Dec 2014
App size: 312 Kb
4.8 ( 9488 ratings )
follow app

Estimation application downloads and cost

> 2.2k
Monthly downloads
~ $ 900
Estimation App Cost


This mobile application was created to facilitate enrollment into the MISTIE-III Clinical Trial. MISTIE-III is a five-year clinical trial designed to demonstrate the safety and long-term efficacy of thrombolysis in the treatment of intracerebral hemorrhage (ICH).

The primary hypothesis of this trial is to demonstrate that minimally invasive surgery (MIS) plus recombinant tissue plasminogen activator (rt-PA) for three days improves functional outcome by a 13% increase in the modified Rankin Scale (mRS) score 0-3 compared to medically treated subjects.
Read more
No search terms founded
Available in countries
Country Price
Canada free
China free
France free
Germany free
Italy free
Netherlands free
Portugal free
Spain free
Poland free
UK free
India free
Japan free
Poland free
Russia free
Turkey free
USA free
Korea, Republic Of free
Ukraine free
Available for devices
iPhone4, iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE, iPhone7, iPhone7Plus, iPad611, iPad612, iPad71, iPad72, iPad73, iPad74, iPhone8, iPhone8Plus, iPhoneX,